Charles River Laboratories Inc. (US) and Lonza (Switzerland) are Leading Players in the Pyrogen Testing Market
The global pyrogen testing market size is projected to reach USD 1,689 million by 2025 from USD 927 million in 2020, at a CAGR of 12.7% during the forecast period. Growth in the pyrogen testing industry is mainly driven by factors such as the rising incidence of infectious diseases and increasing pandemic frequency, increasing & R&D in the pharmaceutical and biotechnology industries, growing focus on personalized medicine, increasing awareness of food safety, and the rising prevalence of chronic diseases. On the other hand, the high degree of market consolidation is expected to limit market growth to a certain extent in the coming years.
The major players in this market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Associates of Cape Cod, Inc. (US), GenScript Biotech Corporation (China), bioMérieux SA (France), FUJIFILM Wako Pure Chemical Corporation (Japan), Eurofins Scientific (Luxembourg), WuXi AppTec (China), Hycult Biotech (Netherlands), Ellab A/S (Denmark), Microcoat Biotechnologie GmbH (Germany), InvivoGen (US), Nelson Laboratories, LLC (US), Almac Group (UK), Pacific Biolabs (US), STERIS plc (US), Accugen Laboratories, Inc. (US), TOXIKON (US), Minerva Analytix GmbH (Germany), Indoor Biotechnologies, Inc. (US), Creative Bioarray (US), Lucideon Limited (UK), and North American Science Associates, Inc. (US).
To know about the assumptions considered for the study download the pdf brochure
Charles River Laboratories accounted for the largest share of the pyrogen testing market in 2019. The company offers a wide range of products and services that span the entire drug discovery and development continuum. Its portfolio for pyrogen testing products includes a range of endotoxin testing systems, LAL reagents, instruments, software, and contract endotoxin testing services. The company focuses on acquisitions to enhance its comprehensive product portfolio. To maintain its leading position and enhance its market share, the company mainly focuses on exceeding customer expectations by maintaining its services and quickly adapting to new conditions with efficiency.
In 2019, Lonza accounted for the second-largest share of the pyrogen testing market. The company has a strong foothold in this market with its extensive range of pyrogen testing products. With its wide geographic presence and high production capacity, the company delivers quality products across the globe. This has helped the company to develop new and advanced products. The company operates through two divisions, namely, Specialty Ingredients and Pharma, Biotech, and Nutrition. Through its Pharma, Biotech, and Nutrition segment, the company offers pyrogen testing products. The company adopted product launches as a key strategy to strengthen its position and expand its product portfolio. In 2019, the company introduced PyroTec PRO Robotic Solution, which accelerates the endotoxin testing of parenteral pharmaceuticals. Also, in 2020, the company launched the PyroCell Monocyte Activation Test System for reliable and sustainable in vitro pyrogen testing. Such developments have helped the company enhance its visibility in the pyrogen testing market.
Merck KGaA focuses on organic growth strategies such as expansions to maintain its leading position in the pyrogen testing market. In March 2019, the company opened a new M Lab Collaboration Center in Molsheim, France. This expansion will provide the company’s pharmaceutical and biotechnology customers access to its Life Science product portfolio and technical expertise. The company also focuses on enhancing its presence in the high-growth Asian region to increase its market share and revenue. In the last three years, the company has opened life science centers in China, India, South Korea, and Singapore.
Related Reports:
Pyrogen Testing Market by Product & Service (Assays, Kits, Reagents, Instruments, Services), Test Type (LAL, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit), End User (Pharmaceutical, Biotechnology, Medical Device), Region - Global Forecast to 2025
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
